Arrowhead Pharmaceuticals, Inc. today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult ...

Department of Biochemistry and Molecular Medicine, University of California at Davis, School of Medicine, Sacramento, CA, United States Small RNA or oligonucleotide therapeutics represent a unique ...

1 PlantLab, Institute of Plant Sciences, Sant’Anna School of Advanced Studies, Pisa, Italy 2 Institute of Agricultural Biology and Biotechnology, National Research Council, Pisa, Italy RNA ...

Some 39,000 years ago, a woolly mammoth died in present-day Siberia, destined to be blanketed by ice and permafrost that would end up preserving its body — even down to the hair and muscle. Now, that ...

A woolly mammoth that was frozen in the Siberian permafrost for nearly 40,000 years has yielded the world’s oldest RNA. The specimen, found in 2010 and nicknamed Yuka, is regarded as the ...

Founded in 1992, Sirna Therapeutics was one of the earliest biotechnology companies focused on developing therapeutics based on RNA interference (RNAi), specifically using small interfering RNA (siRNA ...

Introduction: Atherogenic dyslipidemia contributes to residual cardiovascular risk despite current therapies. ANGPTL3 inhibition is a novel approach to reduce atherogenic lipids. Zodasiran, an RNA ...

It was not until 2018 that the US FDA approved the first therapy developed using the technique. Since then, there’s been a steady, but slow, number of RNAi treatments coming into the market. The ROBO ...

We examine James Comey’s indictment and an investigation into George Soros’s foundation. By Evan Gorelick I’m a writer for The Morning. The Justice Department is giving President Trump what he wants.